Yuyu Pharma Inc Cash Flow Reinvestment Rate
Yuyu Pharma Inc cash flow reinvestment rate. Yuyu Pharma Inc (000225) has a Cash Flow Reinvestment Rate of 1.74x as of June 2026, reinvesting ₩8.57 Billion (capex ₩5.52 Billion plus investments ₩-3.05 Billion) from operating cash flow of ₩4.91 Billion. Explore 000225 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Yuyu Pharma Inc (2014–2025)
Cash flow reinvestment rate of Yuyu Pharma Inc from 2014 to 2025. Historical reinvestment intensity for Yuyu Pharma Inc across 9 annual periods. Explore capital reinvestment ratio of Yuyu Pharma Inc to see what proportion of operating cash flow is directed to capital expenditures.
Yuyu Pharma Inc Cash Flow Reinvestment Rate by Year (2014–2025)
Yuyu Pharma Inc cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. For the full cash flow conversion analysis, see 000225 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | ₩13.38 Billion | ₩15.88 Billion | ₩8.45 Billion | ▲ +126.2% |
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | — |